Gefapixant, a P2X3 receptor antagonist, for the treatment of refractory or unexplained chronic cough: A randomized, double-blind, controlled, parallel-group, Phase 2b trial: Discussions from a Twitter journal club @respandsleepjc (#rsjc). Issue 1 (2nd January 2021)

Record Type:: Journal Article
Title:: Gefapixant, a P2X3 receptor antagonist, for the treatment of refractory or unexplained chronic cough: A randomized, double-blind, controlled, parallel-group, Phase 2b trial: Discussions from a Twitter journal club @respandsleepjc (#rsjc). Issue 1 (2nd January 2021)
Main Title:: Gefapixant, a P2X3 receptor antagonist, for the treatment of refractory or unexplained chronic cough: A randomized, double-blind, controlled, parallel-group, Phase 2b trial: Discussions from a Twitter journal club @respandsleepjc (#rsjc)
Authors:: Kawala, Christopher
Anand, Anju
Stanbrook, Matthew
Abstract:
Is Part Of:: Canadian journal of respiratory, critical care, and sleep medicine =. Volume 5:Issue 1(2021)
Journal:: Canadian journal of respiratory, critical care, and sleep medicine =
Issue:: Volume 5:Issue 1(2021)
Issue Display:: Volume 5, Issue 1 (2021)
Year:: 2021
Volume:: 5
Issue:: 1
Issue Sort Value:: 2021-0005-0001-0000
Page Start:: 72
Page End:: 74
Publication Date:: 2021-01-02
Subjects:: Lungs -- Diseases -- Periodicals
Critical care medicine -- Periodicals
Sleep apnea syndromes -- Periodicals
616.2005
Journal URLs:: https://www.tandfonline.com/toc/ucts20/current ↗
http://www.tandfonline.com/ ↗
DOI:: 10.1080/24745332.2020.1777598 ↗
Languages:: English
ISSNs:: 2474-5332
Deposit Type:: Legaldeposit
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗
Physical Locations:: British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store
Ingest File:: 25318.xml